Short hospitalizations hit hard for COVID patients

Study hints at long-term health and financial impacts.

9:48 AM

Author | Kelly Malcom

three people coughing and looking stressed in black and red
Jacob Dwyer, Michigan Medicine

Even a relatively short hospital stay for COVID-19 can result in long-term health and financial impacts for patients, according to early results from a study funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

The ongoing study, conducted by the NHLBI Prevention and Early Treatment of Acute Lung Injury, also known as PETAL, Network, has enrolled over 1,300 patients at 44 major medical centers. The early analysis includes 253 patients who were hospitalized during the fall of 2020 through early 2021, during the pandemic's so called third wave.

Preliminary analysis finds that close to 85% of people hospitalized for COVID said that they were not back to their pre-COVID lives one month later. And these problems don't appear to be a consequence of age or previous health status—the people surveyed were an average age of 60 years old and in relatively good health before their bouts with COVID-19.

MORE FROM THE LAB: Subscribe to our weekly newsletter

"These people have substantially worse problems after hospitalization than clinicians would have expected," said one of the study's co-lead authors Theodore "Jack" Iwashyna of the Department of Internal Medicine.

Most had a new or worse cardiopulmonary symptom, a finding in line with other studies of so-called long COVID. However, the study reveals other significant factors that may be driving people's inability to make a full recovery.

Almost half of the patients surveyed reported a new disability that prevented them from doing activities of daily living one month later. 

"This isn't patients saying, 'I can't run quite as far as I used to'.  This is them saying 'I can't walk, I can't cook, I can't shower'. The effects are devastating," said co-lead author C. Terri Hough, M.D., Professor of Medicine and Chief, Division of Pulmonary and Critical Care Medicine Oregon Health & Science University.  Hough adds, "Unfortunately, we saw this even among patients with quite short hospital stays."

The average patient included in the study was only hospitalized for five days, and half for less than that. While longer hospitalizations were associated with even more disability and symptoms, problems were present even among those with only short stays, even among the young.

On top of the physical impacts of a hospital stay, the financial fallout was widespread. Twenty-three percent of patients said they had used up their savings, 20% had to either change their job or became unemployed, and close to 40% required a loved one to miss work to provide care.

So far, the study hints at one major risk factor: a lack of follow-up healthcare services. Seventy-seven percent of patients reporting a disability had not received skilled home care following their hospitalization, even when other hospital services were back up and running. "Somewhere the ball is being dropped. One month later, these patients need services and are not getting them," said Iwashyna.

The study is working to identify other ways to improve recovery.

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcasts or anywhere you listen to podcasts.

"As we continue, we're excited that this study will link the biology of initial hospitalizations for COVID-19 to long-term patient-centered outcomes, and thereby help us find treatments to decrease the burden of recovery from COVID-19," said Hough. "There are few other national studies that have both details about the hospital stay and are continuing to ask for patient perspectives like we are."

"While much attention has focused on deaths from COVID, these findings highlight the long-term consequences in survivors of COVID-19 and shed light on the public health crisis resulting from the disability and economic loss among COVID survivors," said James P. Kiley, Ph.D., director of NHLBI's Division of Lung Diseases.

Paper cited: "Continuing Cardiopulmonary Symptoms, Disability, and Financial Toxicity One Month After Hospitalization for 3rd Wave COVID-19: Early Results from a U.S. Nationwide Cohort," Journal of Hospital Medicine. DOI: 10.12788/jhm.3660


More Articles About: Rounds Covid-19 COVID-19 Vaccine Hospitals & Centers infectious disease
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories nurses retreat from glove hand with vaccine
Health Lab
Some Healthcare Providers Among Those Hesitant About COVID-19 Vaccine
Though most healthcare personnel planned to be vaccinated, some were more likely to be reluctant
clock with vaccine as clock hand
Health Lab
Who Gets a Shot First?
While supplies are limited, experts ponder how to get the COVID-19 vaccines to those who need them most.
A health care worker on a COVID-19 unit during the early months of the pandemic.
Health Lab
Leading the Way in Practical Treatment of COVID-19
A Michigan Medicine team has created online guidelines for therapies and practical treatments for COVID-19.
cell phone with vaccine bottle
Health Lab
How to Make Sure People Get the Second Dose of the COVID-19 Vaccine
The first COVID-19 vaccines require two doses for full protection. Money, transportation, reminders and support will help ensure people get both.
Health Lab
Questions and Answers About COVID-19 Vaccine Clinical Trials
Are the vaccine trials being rushed? Are they safe? Two Michigan Medicine researchers weigh in.
Pill capsule pushing through a paper with amoxicillin printed on it.
Health Lab
Rise seen in use of antibiotics for conditions they can’t treat – including COVID-19
Overuse of antibiotics can lead bacteria to evolve antimicrobial resistance, but Americans are still receiving the drugs for many conditions that they can’t treat.